1. Home
  2. ALXO vs NLOP Comparison

ALXO vs NLOP Comparison

Compare ALXO & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$1.79

Market Cap

205.9M

Sector

Health Care

ML Signal

HOLD

NLOP

Net Lease Office Properties of Beneficial Interest

HOLD

Current Price

$11.39

Market Cap

176.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALXO
NLOP
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.9M
176.7M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
ALXO
NLOP
Price
$1.79
$11.39
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
1.4M
110.2K
Earning Date
05-08-2026
05-19-2026
Dividend Yield
N/A
52.20%
EPS Growth
26.36
N/A
EPS
N/A
1.69
Revenue
N/A
$118,915,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$6.78
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$11.24
52 Week High
$2.66
$34.53

Technical Indicators

Market Signals
Indicator
ALXO
NLOP
Relative Strength Index (RSI) 54.99 33.61
Support Level $1.54 $11.34
Resistance Level $2.27 $12.26
Average True Range (ATR) 0.12 0.29
MACD 0.03 -0.02
Stochastic Oscillator 97.62 15.04

Price Performance

Historical Comparison
ALXO
NLOP

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

About NLOP Net Lease Office Properties of Beneficial Interest

Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns, operates, and finances a diversified portfolio of office properties mainly leased to corporate tenants on a single-tenant, net-lease basis. The company operates as a single operating and reportable segment focused on owning and managing office properties that generate revenue mainly from long-term lease agreements with tenants.

Share on Social Networks: